强化生活方式管理改善儿童非酒精性脂肪性肝病的脂肪变性与纤维化
这项前瞻性研究纳入204例因重度肥胖入住比利时三级中心的儿童和青少年,采用强化生活方式治疗(热量限制、体力活动、健康教育及心理社会支持)。6个月时中位体重下降16.0%,75.0%的患者纤维化改善(P < .001);1年时所有基线有纤维化者纤维化至少消退1期。结论认为强化多学科生活方式管理带来的显著体重下降不仅改善肝脂肪变性,也改善纤维化。
要点
- 204例重度肥胖儿童青少年入院时超声诊断NAFLD占71.1%,68.6%的CAP值≥248 dB/m。
- 32.8%的患者至少有F2纤维化,其中10.3%的瞬时弹性成像值≥9 kPa。
- 6个月时167例评估者中位体重下降16.0%,75.0%纤维化改善(P < .001)。
核心结论
- NAFLD及相关纤维化在重度肥胖儿童和青少年中高度流行;强化多学科生活方式管理项目带来显著体重下降,不仅改善肝脂肪变性,也改善纤维化。
研究设计与样本
- 前瞻性研究,纳入因重度肥胖入住比利时三级中心(Zeepreventorium, De Haan, Belgium)的儿童和青少年,共204例(中位年龄14.0岁;BMI Z评分+2.8)。
- 强化生活方式治疗包括热量限制、体力活动、健康生活方式教育和心理社会支持。
- 在基线、6个月和12个月时进行肝脏超声和带受控衰减参数的瞬时弹性成像,评估肝脂肪变性和纤维化。
主要发现
- 入院时超声诊断NAFLD占71.1%,68.6%的患者受控衰减参数值≥248 dB/m。
- 32.8%的患者至少有F2纤维化,包括10.3%的患者瞬时弹性成像≥9 kPa。
- 6个月后,167例评估患者的中位体重下降为16.0%;纤维化改善者占75.0%(P < .001)。
- 基线肝纤维化和脂肪变性严重程度是纤维化消退的预测因素。
- 79例患者达到1年时间点;纤维化改善得以维持,所有基线有纤维化的患者纤维化至少消退1期;空腹血清丙氨酸氨基转移酶和稳态模型评估胰岛素抵抗指数在1年期间显著下降(P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Childhood obesity, with associated comorbidities such as nonalcoholic fatty liver disease (NAFLD), is an increasing global health problem. Although lifestyle management is the mainstay of treatment, its efficacy on liver fibrosis has not yet been established. METHODS: Children and adolescents admitted for severe obesity at a tertiary center (Zeepreventorium, De Haan, Belgium) were enrolled in this prospective study. Intensive lifestyle therapy encompassed caloric restriction, physical activity, education on a healthy lifestyle, and psychosocial support. At baseline, 6 months, and 12 months, liver ultrasound and transient elastography with controlled attenuation parameter were performed to assess liver steatosis and fibrosis. RESULTS: A total of 204 patients (median age, 14.0 y; body mass index Z-score, +2.8) were evaluated at admission. NAFLD on ultrasound was present in 71.1%, whereas 68.6% had controlled attenuation parameter values of 248 dB/m or greater. A total of 32.8% of patients had at least F2 fibrosis, including 10.3% with transient elastography of 9 kPa or greater. After 6 months, the median body weight loss was 16.0% in the 167 patients evaluated. Fibrosis improved in 75.0% (P < .001). Baseline severity of liver fibrosis and steatosis were predictors of fibrosis resolution. Seventy-nine patients had reached the 1-year time point. The improvements were sustained because fibrosis regressed at least 1 stage in all patients with baseline fibrosis. Fasting serum alanine aminotransferase and homeostasis model assessment of insulin resistance decreased significantly over the 1-year period (P < .001). CONCLUSIONS: NAFLD and associated fibrosis are highly prevalent in children and adolescents with severe obesity. An intensive multidisciplinary lifestyle management program that causes significant weight loss not only improves liver steatosis, but also fibrosis.
引用
- Lefere S, Dupont E, De Guchtenaere A, et al. Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021. PMID: 34871812. doi:10.1016/j.cgh.2021.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。